|】 【 Exhibition Overview 】|
|The 8th China and World Pharmaceutical Entrepreneurs Summit||World Pharmaceutical. Pujiang Night|
|Medical Women Leadership Salon|| CPhI Pharma Business |
|[Onsite meetings and events]|
| CPhI International Agencies Updates and Q & A Session |
-June 21, 2017-
| CPhI CRO & CMO Forum CPhI CRO & CMO Forum |
-June 20, 2017-
| CPhI Formulation Companies Salon |
2017 CPhI preparation internationalization experience sharing and exchange salon
-June 21, 2017-
| China Pharma Environmental Forum |
-June 20, 2017-
Learn about the latest developments in global pharmaceutical policy and the latest international pharmaceutical regulatory rules and registration processes. 2017 International Pharmaceutical Administration Q & A brings together experts from CFDA National Pharmacopoeia Commission, CFDA Review and Inspection Center, Shanghai Drug Administration, WHO, US FDA, EDQM, MHRA and other domestic and foreign pharmaceutical regulatory agencies to explore international markets for Chinese companies and understand international The rules provide the most authoritative information service, promote the exchange and interaction between the Chinese pharmaceutical industry and domestic and foreign drug regulatory agencies, and promote the internationalization of the Chinese pharmaceutical industry.
With the increasing R & D costs of pharmaceutical companies, major pharmaceutical companies have outsourced more drug R & D and production to CROs and CMOs in order to improve R & D efficiency. Professional CROs and CMOs and their unique technology platforms have also become the most important part of the new drug development ecosystem. During the CPhI R & D Day, the CPhI CRO & CMO Forum invited CRO / CMO experts from Patheon, Nanjing Yaoshi, Rundong, Colin Likang, WuXi AppTec and other pharmaceutical companies, as well as pharmaceutical companies from Johnson & Johnson, Roche, Agios, etc. to purchase and supply Experts gathered to discuss how pharmaceutical companies and CRO / CMOs can achieve a win-win situation through cooperation. The conference attracted nearly 120 industry managers and experts.
The role of Chinese medicine in the global industrial chain has gradually extended from the field of raw materials to the field of preparations. More and more local pharmaceutical companies have joined the process of internationalization of preparations. Representatives from Zhejiang Huahai Pharmaceutical, Dongguang Sunshine Pharmaceutical Group, Sansheng Pharmaceutical Group, Wuxi Meixi, Guilin Nanyao, CSPC, Nanjing Famakai and other leading pharmaceutical exporters in the industry and more than 130 companies from more than 80 companies Representatives attended the salon. The information sharing and experience sharing of the leading enterprises at the meeting played a good reference role for the participating enterprises to formulate their own foreign trade strategies and market expansion strategies.
On June 20-21, the organizer, in conjunction with the China Environmental Protection Federation and the Yangtze River Delta Green Pharmaceutical Cooperative Innovation Center, hosted two "green pharmaceutical" themed forums, with green technology as the core, and comprehensively promoting green manufacturing in the pharmaceutical industry. The “Green Pharmacy and Environmental Protection Symposium” with a strong lineup of speakers covered topics on environmental protection macro policies and technology application solutions, attracting more than 100 listeners. The "Green Chemical and Pharmaceutical Technology Forum" launched a lively discussion on the latest process trends, development trends, academic hotspots, technical cooperation, and industrial hotspots in the pharmaceutical field, attracting more than 112 listeners.
| P-MEC China Summit 2017 The 6th P-MEC China Pharmaceutical Engineering Summit |
-June 20-22, 2017-
| 2017 International Summit on Pharmaceutical Packaging and Drug Delivery Systems |
2017 Global Pharmaceutical Excipients Development Forum
-June 20-21, 2017-
| Natural Ingredient Conference 2017 Natural Product Innovation and Development Forum (NIC2017) |
-June 21, 2017-
| 4th China BioPh Outlook Summit |
-June 20-21, 2017-
The three-day summit invited 13 heavyweight guests from the government, multinational pharmaceutical companies and consulting companies. On the basis of comprehensively summarizing the development of the pharmaceutical industry policy in recent years and the results and experience achieved by automation and informatization, Discuss the development trend of future pharmaceutical factories with more than 300 participants at the site.
With the increasing competition in the global pharmaceutical market, how to improve the way and method of administration, optimize the packaging materials and pharmaceutical excipients, to achieve faster and more accurate efficacy and improve the patient's drug experience has become the focus of pharmaceutical companies one. More than 20 industry experts from the government, multinational pharmaceutical companies and high-quality supply companies proceeded from the development and implementation of policies and brought topics such as supplier management, user experience optimization, and product innovation to more than 110 audiences on the spot.
The forum invites domestic and foreign government authorities and front-line experts to focus on the international market of extracts, share changes in global regulations, track US Pharmacopoeia standards, and interpret the principles of classification of customs codes, which will serve as a pulse for the development of the industry and guide the development of enterprises. repercussions. Chairman of the China Medical Insurance Chamber of Commerce Plant Extracts Branch Zhang Chengwen, Chairman of Chongqing Jiaowang Natural Products Co., Ltd .; Ding Linwei, National Customs Import and Export Commodity Classification Center Guangzhou Branch; Ma Yuanchun, Founder of Canadian Natural Pharmaceutical Group; Yu Zhibin, the secretary general of the chapter, and experts from the United States NSF gave speeches. The forum also released the third batch of international business standards for plant extracts and announced 25 standards for the fourth batch of projects.
The two-day summit invited more than 20 senior pharmaceutical company executives from BMS, Novartis, GSK, WuXi Bio, Cinda Bio, and SmartChem, and more than 120 elites from domestic and overseas pharmaceutical companies and biotechnology companies Together, focusing on the four major segments of the pharmaceutical market, precision medicine, protein and peptide drugs, and antibody drug development, talk about the future of China's biopharmaceuticals.
|CPhI R & D Day CPhI "R & D Day" Activities-Special R & D Visits||CPhI China Pharmaceutical Excipients Discovery Tour CPhI China Pharmaceutical Excipients Discovery Tour|| Pharmaceutical Packaging & Drug Delivery System Innovation Gallery & Tour ||Clean Door Innovation Tour|
Since the CPhI R & D Day event in 2015, more than 3,700 pharmaceutical R & D personnel have actively participated in the event. In 2017, CPhI China ’s official organization “CPhI R & D Alliance” planned another “R & D Day” event during the exhibition, and tailored a “R & D special visit route” for audiences in the field of biomedicine R & D. The route included four R & D conferences and three Special events are located in the four related exhibition areas of Halls E2, W5, N1, and T5. In addition, there is a more exquisite and exclusive "R & D Day Map" on the site, which will more intuitively show the R & D information to the audience and enhance the audience's viewing experience.
The organizer specially created a brand-new exhibitor and audience interactive activity for the pharmaceutical excipients zone. This event was led by pharmaceutical excipient experts and visited a number of high-quality pharmaceutical excipient exhibitors, leading the audience to experience German pharmaceutical agents, Different attitudes of leading pharmaceutical auxiliary companies such as Huzhou Prospect and Shanhe Pharmaceutical. The audience at the site listened carefully to the exhibitors' introduction of popular products such as hypromellose, hollow capsules, polyethylene glycol, and microcrystalline cellulose. This event aims to help domestic and foreign buyers to find high-quality high-quality pharmaceutical excipient products and suppliers faster, and to better understand the latest products, innovative technologies and industry trends at home and abroad.
This year's event features themes "Most Popular Suppliers", "Functional Packaging and Drug Delivery Systems", and "Biological Packaging", bringing viewers quality products that excel in compliance, durability, and automation. . The high-quality products of the participating companies and the enthusiastic response of visitors confirm that innovation and humanization are not only the positioning of InnoPack China, but also the core of the development of the pharmaceutical packaging industry.
Wang Hongzhou, an expert of Suzhou Cleanliness Association, led the team to explain the event, and invited professional visitors from the pharmaceutical engineering department, equipment technology department, purchasing department and other professional visitors to participate in the "purification door" tour, and quickly arrived at the "purification door" boutique booth. Product experts communicate in depth. The full series of various special clean doors, such as the "zipper quick door" exhibited for the first time, showed the latest clean door products and market development trends for participants, and the atmosphere of the lively exchange was warm.
|["Purchasing Meeting + New Media + Live Broadcast + VR"]|
|International Business Opportunities Successfully Held the 7th CPhI Pharmaceutical Online Procurement Meeting|| Practical dry food sharing teaches you how to play mobile Internet |
2017 "CPhI Pharmaceutical Online" New Media Innovation Marketing Forum
| Focus on industry events and listen to the voice of big coffee. |
"CPhI started talking" live broadcast
In addition, the “365 ° VR Panorama Experience” and “Lucky Turntable” held concurrently by “CPhI Pharmaceutical Online” also attracted nearly 3,000 enthusiasts to participate in the interaction. The VR panorama screens of 100 exhibiting companies ’booths allowed more audiences to come Environment, staying at home to appreciate the grand occasion of the exhibition.
The procurement meeting was attended by 123 buyers and organized 506 negotiations between buyers and sellers. The procurement products covered more than 2504 categories in 24 categories. The successful holding of the procurement meeting was based on the strong data of "exhibition" + "website". With regard to the way of face-to-face negotiation, the professional service team helps Chinese suppliers to establish cooperative relations with international buyers, thereby effectively closing the distance between the two parties and promoting business.
This forum strongly invites industry experts to provide practical dry goods sharing under the theme of WeChat Mini Programs, Communities, Live Broadcast and other new social media, to guide companies how to make better use of new media, how to transform traditional enterprises, and grasp the next one. tuyere. This forum attracted more than a hundred people to listen and enthusiastically asked questions. Many audiences said that the content is particularly practical and novel, full of dry goods, and they will consider trying to use it in the company's marketing.
At CPhI & P-MEC China 2017, medical scholars from home and abroad gathered together to focus on the pharmaceutical industry and bring valuable industry information to the industry. "CPhI started talking" went straight to the scene for the first time, an exclusive interview with the industry's most concerned about pharmaceutical big coffee, brought 17 live interviews with senior experts, from policy interpretation, high-tech, production applications, development trends, new products and other aspects , Directly hit the hot spot of the current pharmaceutical industry, online and offline easy to enjoy the exhibition.
Audience data analysis
Exhibitor data analysis
|About Us - Contact Us - Announcement - Terms of Service - Site Help - Business Services - Legal Statement - Legal Advisors|
|Su ICP No. 05005804 Value-added Telecommunications Business License Su B2-20080174|